Guide
Nerve support supplements: a reader’s guide
Nerve support is a positioning rather than a formula. There is no standard recipe in this category, no required ingredient and no approved claim, so a reader has nothing to compare a bottle against except the bottle itself. This guide sets out the three things that decide one: the claim on the front, the blend on the back, and the arithmetic that occasionally cracks it open.
Three things matter in this category and the first is a line drawn by law. A supplement may say it supports a normal structure or function of the body; it may not say it diagnoses, treats, cures or prevents a disease, because — in the FDA’s own words — only a drug can legally make such a claim. The second is the proprietary blend, which lets a label declare one total and withhold every individual amount. The third is the technique this product makes possible: when a panel declares an element sourced from a named compound inside a blend, the blend can be solved rather than merely bounded. On this label that turns a 575 mg blend of six into about 567.5 mg of one ingredient and about 7.5 mg for the other five together.
- Category
- Nerve support
- Claim type permitted
- Structure/function
- Claim type not permitted
- Disease claims
- Label front
- NERVE SUPPORT FORMULA
- Marketing graphic
- NEUROPATHY SUPPORT FORMULA
- Blend
- 575 mg, six ingredients
- Federal fact sheets
- Four of six
- Price
- Not published anywhere
What the category actually is
Supplements sold for nerve comfort have no defining ingredient. Some are B-vitamin products. Some are mineral products. Some are botanical blends. The only thing they reliably share is a word on the front of the bottle, and that word is chosen under a constraint most readers never see.
Because the category has no standard, the usual consumer shortcuts fail. There is no recommended daily amount for nerve support to measure a bottle against, no required disclosure beyond what every supplement must declare, and no body that rates products in it. Comparison has to be done on documents: what each panel declares, how much of it is quantified, and whether the ingredient names are precise enough to look up.
That is also why this desk reads two federal bodies and no others. NCCIH’s Herbs at a Glance index and the NIH Office of Dietary Supplements fact sheets are public, stable, and not selected by anybody with something to sell. The cost of that rule is that an ingredient with a journal literature but no federal fact sheet gets nothing said about it here, in either direction — and on this label two of the six ingredients are in exactly that position.
What this product is, in one sentence
A single capsule, taken once daily, declaring 80 mg of elemental magnesium at 19% of the Daily Value, above a 575 mg proprietary blend naming magnesium glycinate, alpha lipoic acid, butcher’s broom root extract, L-carnitine, turmeric rhizome extract standardised to 95% curcuminoids, and coenzyme Q10. One figure is printed. Everything else on this page is either arithmetic from that figure or an absence.
Structure/function against disease: the line that defines this category
This is the centre of the guide. Everything else on a nerve-support bottle sits downstream of one regulatory distinction, and once a reader can see it, a whole class of marketing becomes legible.
“Structure/function claims may describe the role of a nutrient or dietary ingredient intended to affect the normal structure or function of the human body … the disclaimer must state that the product is not intended to “diagnose, treat, cure or prevent any disease,” because only a drug can legally make such a claim.”
U.S. Food and Drug Administration — Structure/Function Claims
Read that quotation twice, because it contains both halves. The first half is permission: a supplement may describe the role of a nutrient or dietary ingredient in affecting the normal structure or function of the body. Supports nerve health. Supports comfort. Those are structure/function claims, they require the disclaimer, and they are entirely lawful.
The second half is the reason the disclaimer exists at all. The product is not intended to “diagnose, treat, cure or prevent any disease” — “because only a drug can legally make such a claim”. A disease claim is not a stronger version of a structure/function claim. It is a different category of statement, available to a different category of product, reached by a different route that includes clinical evidence and pre-market review.
So the practical test for a reader is simple: does the wording name a condition? Nerve health names a body system. Neuropathy names a disease. The first is a claim a supplement is permitted to make with a disclaimer attached. The second is not, and the distance between them is not stylistic.
Why the line matters to you rather than to a regulator
A product that stays inside structure/function language is telling you something true about its own position: it has not been assessed as a treatment for anything, and it is not offered as one. A graphic that reaches for a disease word is borrowing credibility the product has not been granted. The distinction protects a reader who has a real symptom from buying a supplement instead of getting an explanation.
The worked example: one product, two bottles
This product is an unusually clean illustration, because the split is not between careful language and sloppy language. It is between two renderings of the same bottle, and only one of them is the bottle.
| Claim | Where it appears | Which kind of claim |
|---|---|---|
| “Nerve Support Formula” | On the label, front panel, with an asterisk | Structure/function. It describes support for a normal body system and names no condition. The asterisk points at the FDA disclaimer printed on the same label. |
| “Nerve Health*” | On the label, front panel icon | Structure/function. Asterisked, generic, and tied to the disclaimer. |
| “Comfort Support*” | On the label, front panel icon | Structure/function. Vaguer still, which in regulatory terms is safer rather than worse. |
| “Nutritional Support” | On the label, front panel icon | Structure/function. On this product it is also the most defensible of the four, because a declared nutrient at 19% of its Daily Value is literally nutritional support. |
| “Neuropathy Support Formula” | Marketing graphic only — not on the label | Names a disease. Neuropathy is a medical condition. The FDA’s own page on structure/function claims explains that the mandatory disclaimer exists because a supplement is not intended to diagnose, treat, cure or prevent any disease, since only a drug can legally make such a claim. |
| “Nerve-comfort positioning by name. Not a drug.” | Seller pack, in its own words | The pack’s own internal instruction, and a careful one. It is recorded here because it shows the distinction was understood by somebody before the artwork was drawn. |
The label is careful and this desk credits it plainly. Nerve Support Formula, three asterisked structure/function icons, and the FDA disclaimer printed in full on the same label. There is no disease word anywhere on the bottle, and the asterisks do what asterisks are for.
The Inside Neuralisse marketing graphic then renders the same bottle as a NEUROPATHY SUPPORT FORMULA, twice. Neuropathy is a named medical condition. Nobody at this desk can say how that happened, and nothing supplied explains it; what can be said is that the label earns marks the artwork gives back, which is exactly how the editorial score records it.
What a reader should do when the two disagree
Treat the label as the product. The bottle that arrives carries the label, the label is the document with rules attached to it, and the graphic is artwork that can be redrawn at any time without telling you. Print both, believe the label, and treat the gap itself as information about how carefully the product is being sold. The one-word finding is published in full here.
One limit on that finding, stated plainly because it matters: this is an observation about artwork, not about contents. Nothing about the word on a graphic tells a reader anything about what is in a capsule. The contents question is answered by the panel, and the panel is the next section.
The proprietary blend problem
A proprietary blend is the standard way a supplement declares its formula without declaring its formula. It is lawful, it is common, and it is the single largest obstacle to reading a label in this category.
“You must identify proprietary blends by use of the term “Proprietary Blend” or an appropriately descriptive term or fanciful name. On the same line, you must list the total weight of all “other dietary ingredients” contained in the blend. Indented underneath the name of the blend, you must list the “other dietary ingredients” in the blend, either in a column or linear fashion, in descending order of predominance by weight.”
U.S. Food and Drug Administration — Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling
Three obligations in that paragraph, and one conspicuous absence. The blend must be named. Its total weight must be printed on the same line. The constituents must be listed underneath in descending order of predominance by weight. What is not required is any individual amount, and Operation Supplement Safety states the consequence in a single sentence:
“The specific amount of each individual ingredient in a proprietary blend does not have to be listed … The only way to know what is in any particular dietary supplement product is through laboratory testing.”
Operation Supplement Safety, U.S. Department of Defense — Proprietary blends: What does this mean?
The descending-order rule is the only foothold a reader is given, and it is a real one. If six items are listed heaviest first inside 575 mg, the item in position n cannot weigh more than 575 divided by n — otherwise n items each at least that heavy would exceed the total. That yields ceilings of 575, 287.5, 191.7, 143.8, 115 and 95.8 mg. Every one is an upper limit and not one is an amount.
The table above is already the tightened version, which is the subject of the next section. The point to carry out of this one is the general shape of the problem: on almost every blend in this category, a reader gets a total, a count and an order, and nothing else. Ceilings are what that buys. They are genuinely useful for comparing two labels, and they are not amounts.
When a blend can be solved outright
There is a second route into a blend and it is rarely available. It does not come from inside the blend at all; it comes from a row above it. This is the technique this product makes possible, and it is worth learning in general before looking at the particular case.
The general move
A mineral is almost never put into a capsule as the bare metal. It is carried by a compound — an oxide, a citrate, a chelate — and the compound weighs more than the mineral inside it, because the rest of the molecule weighs something too. Supplement panels declare the element: when a panel says Magnesium 80 mg, it means eighty milligrams of magnesium, not eighty milligrams of whatever is carrying it.
Every compound has a fixed percentage of the element by weight, and that percentage is arithmetic rather than opinion. Take the atomic mass of the element, divide it by the molar mass of the compound, and you have the fraction. Divide the declared amount of the element by that fraction and you have the weight of the compound. There is no judgement anywhere in the chain.
Now the key step. If the panel names which compound and says it comes from the proprietary blend, the weight you have just calculated is a weight that must be found inside the blend total. It is no longer a ceiling on anything: it is a quantity the blend has to contain. Subtract it from the total and what remains is everything else in the blend, combined. The descending-order rule then divides that remainder, not the whole.
The worked case
This panel declares Magnesium 80 mg, 19% of the Daily Value, (as Magnesium Glycinate from proprietary blend). Magnesium bisglycinate is Mg(C2H4NO2)2, molar mass 172.42 g/mol, of which magnesium accounts for 24.305 — so the chelate is 14.1% magnesium by weight. Eighty divided by 0.141 is about 567.5 mg of chelate, and the blend is 575 mg. The first ingredient is 98.7% of the blend, and about 7.5 mg is left for alpha lipoic acid, butcher’s broom, L-carnitine, turmeric and coenzyme Q10 together.
- 01Start with the one printed figureThe panel declares 80 mg of magnesium above the blend and says it comes from the magnesium glycinate from proprietary blend. That is an amount of the element, not of the compound.
- 02Check that the label’s own percentage agreesThe panel prints 19% of the Daily Value beside it. The NIH Office of Dietary Supplements gives the Daily Value for magnesium as 420 mg, and 80 ÷ 420 = 19.05%. The label’s arithmetic is correct, which confirms the 80 mg is elemental magnesium.
- 03Work out what the compound weighsMagnesium bisglycinate is Mg(C2H4NO2)2. Its molar mass is 172.42 g/mol, of which magnesium accounts for 24.305. The chelate is therefore 14.1% magnesium by weight.
- 04Divide80 ÷ 0.141 = 567.5 mg of magnesium glycinate. That is the weight of the first ingredient in the blend, and it is not a ceiling — it is forced by a printed figure.
- 05SubtractThe blend is 575 mg. 575 − 567.5 = 7.5 mg for alpha lipoic acid, butcher’s broom, L-carnitine, turmeric and coenzyme Q10 together. The first ingredient is 98.7% of the blend.
- 06Apply the descending-order rule to what is leftThe FDA requires blend ingredients “in descending order of predominance by weight”, so inside that 7.5 mg remainder item n cannot exceed 7.5 ÷ n: at most 7.5, 3.7, 2.5, 1.9 and 1.5 mg. Every one of those is a ceiling, not an amount.
The label’s own percentage is what proves the reading. If the 80 mg were a weight of the compound rather than of the element, the percentage printed beside it would not be 19%. It is, and 80 ÷ 420 = 19.05%, so the figure is elemental magnesium. The label’s correct arithmetic is the hinge of the whole analysis — which is a strange kind of credit, but it is a credit.
The first bar is the one ingredient whose weight is fixed by a printed figure. The second is everything else in the blend added together. The five below it are the ceilings the descending-order rule puts on each one inside that remainder. A ceiling is a ceiling, not an amount.
One assumption, stated and tested
The derivation rests on reading Magnesium Glycinate as magnesium bisglycinate at 14.1% magnesium, which is the plain reading of the printed name. If the ingredient were a buffered blend of glycinate and oxide, the percentage would be higher and the chelate weight lower. A sensitivity table for that single assumption is published with the derivation, and even at a generous 25% magnesium the chelate would still be 320 mg of a 575 mg blend. The direction of the finding does not depend on the assumption; the size of it does.
How much tighter that is
It is worth seeing the two sets of ceilings side by side, because the difference is not marginal. The left-hand column is what any reader gets from a 575 mg blend of six. The right-hand column is what the magnesium declaration forces.
| Position | Ordinary ceiling, 575 ÷ n | Mass-balance figure | How much tighter |
|---|---|---|---|
| 1 · Magnesium Glycinate | 575 mg | about 567.5 mg — a weight, not a ceiling | — |
| 2 · Alpha Lipoic Acid | 287.5 mg | at most 7.5 mg | about 38× |
| 3 · Butcher’s Broom root extract | 191.7 mg | at most 3.7 mg | about 52× |
| 4 · L-Carnitine | 143.8 mg | at most 2.5 mg | about 58× |
| 5 · Turmeric extract, 95% curcuminoids | 115.0 mg | at most 1.9 mg | about 61× |
| 6 · Coenzyme Q10 (ubiquinone) | 95.8 mg | at most 1.5 mg | about 64× |
The ratios run from about thirty-eight to about sixty-four. That is the value of the technique: the ordinary ceilings on this label are so loose as to be nearly useless, and they would have let a reader imagine 143 mg of L-carnitine where the mass balance allows at most 2.5 mg.
Position one changes character rather than size. Under the ordinary rule it is capped at the whole 575 mg, which tells a reader nothing. Under the mass balance it is fixed at about 567.5 mg, which is not a ceiling at all but a weight forced by a printed figure. It is the only such figure on this label and the only one in the series so far.
Say it the same way every time
A ceiling is a ceiling, not an amount. The five figures in the right-hand column are upper limits: the true amounts are at or below them, and nothing on the label narrows them further. Drop the qualifier and the number becomes a fabrication the moment somebody quotes it — which is exactly how a derived figure ends up in a product description as a dose.
What can and cannot be cited
Before any discussion of dose there is a prior question: has either body this desk reads published anything about the ingredient at all? Here is the answer for all six.
| Ingredient | Fact sheet found? | What it covers |
|---|---|---|
| Magnesium | Yes — NIH ODS | A Daily Value of 420 mg, an upper limit of 350 mg for supplemental magnesium, and a named role in nerve impulse conduction. The strongest ingredient-level file in the series. |
| Alpha lipoic acid | No | — |
| Butcher’s broom (Ruscus aculeatus) root extract | No | — |
| L-carnitine | Yes — NIH ODS | Trials at 0.25 to 4 g a day for 2 to 52 weeks, and a plain statement that healthy children and adults do not need to consume carnitine from food or supplements. |
| Turmeric (Curcumalonga) rhizome extract, 95% curcuminoids | Yes — NCCIH | Not enough is known to conclude whether turmeric or curcumin is beneficial for any health purpose; oral turmeric can cause digestive adverse effects, and highly bioavailable curcumin has been linked to liver damage in some people. |
| Coenzyme Q10 (ubiquinone) | Yes — NCCIH | No serious side effects reported, with one specific exception: it may interact with warfarin and with insulin. Peripheral neuropathy is not among the conditions the page covers. |
Four of six return something, which is the best rate of any product in this series. Magnesium, L-carnitine, turmeric and coenzyme Q10 all have federal fact sheets. Alpha lipoic acid and butcher’s broom return nothing at NCCIH’s Herbs at a Glance index and nothing at the NIH Office of Dietary Supplements, so this site publishes no dose and no effect for either.
That rule costs those two ingredients the benefit of the doubt, and the cost is deliberate. There is a journal literature on alpha lipoic acid; selecting which papers to quote is exactly the step that turns an information page into a sales page, so this desk does not take it. Absence of a federal fact sheet is not evidence of harm and not evidence of benefit. It is absence of information, and it is reported as that.
The one ingredient on this label with a published study range, set against that range. NIH ODS records L-carnitine trials at “0.25 to 4 g/day”. The ceiling here is about 2.5 mg: between one hundred and one thousand six hundred times smaller. ODS also records that healthy adults do not need supplemental carnitine.
That comparison is the one that settles most products in this category, and it is the starkest in the series. A ceiling of about 2.5 mg against a published range of 250 to 4,000 mg is a gap of roughly one hundred to one thousand six hundred times. The same fact sheet also records that healthy children and adults “do not need to consume carnitine from food or supplements”, which cuts both ways and is printed here for that reason.
How to assess any product in this category
Eight steps, in order. They work on any nerve-support bottle, they require nothing but the label and two public websites, and they end with the one question only the seller can answer.
- 01Read the front panel and write down every claim word for wordIncluding the asterisks. Then do the same for the advertisement, the product page and any graphic supplied with it. You are looking for a named condition — a disease word — appearing in one place and not the other. On this product the word is neuropathy and it appears only in the marketing.
- 02Find the FDA disclaimer and check it is printed in fullThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Its presence is a legal requirement rather than a confession, and its absence beside a structure/function claim would be the thing worth noticing. This label prints it in full.
- 03Count the blend, then look above it for a declared nutrientThe total and the count give you the ordinary ceilings. A declared nutrient with a percentage beside it, attributed to a compound inside the blend, gives you something much stronger. Check the bracket: from proprietary blend is the phrase that matters.
- 04Take every named ingredient to a federal fact sheet, not to a search engineNCCIH’s Herbs at a Glance index and the NIH Office of Dietary Supplements fact sheets are the two this desk reads. If an ingredient returns nothing at either, publish no dose and no effect for it. Two of the six here return nothing, and that is reported as missing information rather than as a verdict.
- 05Set every ceiling against a published dose, where one existsThis is the step that settles most products in this category. The only ingredient here with a published study range is L-carnitine, at 250 to 4,000 mg, against a ceiling of about 2.5 mg. Where no dose is published — as for alpha lipoic acid and butcher’s broom — say so rather than inventing a comparison.
- 06Read the caution block as the only part written for your bodyDose limit, age, pregnancy and nursing, medication, medical conditions. This product’s block covers all five, which is better than most. Then check whether anything the ingredients carry is missing from it — here, the word warfarin appears nowhere on the product.
- 07Ask the order desk for a Certificate of Analysis before you decideA blend is only ever settled from outside the panel. Ask for the certificate for the lot you were sent, by lot number. The script for that call is published here. If no certificate exists, that answer is itself information.
- 08Write down what is not published, and leave it written downNo amount for five of six ingredients. No manufacturer, only a distributor. No country of origin. No certificate. No price in any document supplied. No guarantee length. Absence is a finding; it stays not published rather than becoming unclear.
Run on this product, that sequence produces a label with real credits and a formula with one ingredient in it. The panel is complete and its arithmetic is right. The naming is the best in the series. The caution block covers everything it should. And about 98.7% of the active blend is a magnesium chelate, with roughly 7.5 mg left for five named ingredients that the front of the bottle gives equal billing.
When to stop reading and make an appointment
This is a category bought by people with symptoms, so the most useful paragraph on the page is not about labels at all.
Nerve symptoms that have not been explained by a clinician are a reason to see one. Numbness, tingling, burning or weakness have many causes. Some are benign, some are reversible if addressed and some are not, and the difference is not something a label can tell you. Buying a supplement instead of getting an explanation substitutes a purchase for a diagnosis, and that is the one decision this guide exists to warn against.
Three specific things are worth raising with a prescriber before taking this particular product, none of which appears on the bottle in those words. NCCIH records that coenzyme Q10 “may interact with the anticoagulant (blood thinner) warfarin and the diabetes drug insulin”; at a ceiling of about 1.5 mg that is context rather than a warning, but the word warfarin appears nowhere on the product. The NIH Office of Dietary Supplements sets the upper limit for supplemental magnesium at 350 mg a day, so this capsule’s 80 mg should be added to anything else you already take. And NCCIH records that turmeric use during pregnancy “may be unsafe”, which the label’s own caution block already covers by excluding pregnant and nursing mothers.
What the label itself says, and it says it well
Do not exceed recommended dose. Not for use for those under the age of 18 or pregnant or nursing mothers. Consult with a physician prior to use especially if you are taking a medication or have a medical condition. That block names the dose limit, the age restriction, pregnancy and nursing, medication and medical conditions. Several products in this series manage less, and this one is credited for it.
Common questions about nerve supplements
These are the questions people type about this category and this product. Type to filter them.
what is a nerve support supplement
A dietary supplement sold with a structure/function claim about nerve function or comfort. It is not a drug and it is not approved by the FDA before sale. The category has no standard formula: this one is a single capsule carrying 80 mg of declared magnesium above a 575 mg blend of six named ingredients. What any particular bottle contains is a question about its own panel, not about the category.
is neuralisse fda approved
No, and no dietary supplement is. The FDA states in its own words that under the governing statute it “does not have the authority to approve dietary supplements before they are marketed”. That is how the whole category works rather than a fault in this product. Responsibility for the claims on the bottle and for the safety of the contents sits with the company that makes and markets it.
what is a proprietary blend
A named group of ingredients declared as one total weight, with the individual amounts withheld. It is permitted. Operation Supplement Safety, run by the US Department of Defense, states that the amount of each individual ingredient “does not have to be listed”. The FDA requires the total on the blend line and the constituents underneath in descending order of weight, which is the only foothold a reader gets.
how much of each ingredient is in a proprietary blend
Normally you cannot know, and nobody can tell you from the label alone. The descending-order rule gives ceilings: item n cannot exceed the total divided by n. On this label there is a second route, because 80 mg of magnesium is declared as coming from the magnesium glycinate inside the blend, which fixes that ingredient at about 567.5 mg and leaves about 7.5 mg for the other five together. Those five figures remain ceilings, not amounts.
can a supplement treat neuropathy
No supplement may claim to. The FDA’s page on structure/function claims explains that the mandatory disclaimer exists because a product is not intended to diagnose, treat, cure or prevent any disease, since “only a drug can legally make such a claim”. This product’s own label stays on the right side of that line and says nerve support formula. Unexplained nerve symptoms are a reason to see a clinician.
why does the bottle say nerve support and the advert say neuropathy support
This desk does not know, and nothing supplied explains it. The flat label artwork reads NERVE SUPPORT FORMULA. The Inside Neuralisse marketing graphic renders the same bottle as NEUROPATHY SUPPORT FORMULA, twice. Both are printed on this site. Where they disagree the label is the product, because the label is what arrives on the bottle.
does magnesium help nerve pain
The NIH Office of Dietary Supplements records that magnesium helps move calcium and potassium ions across cell membranes, a process “important to nerve impulse conduction, muscle contraction, and normal heart rhythm”, and that as deficiency worsens “numbness, tingling, muscle contractions and cramps” can occur. Read that precisely: it describes what happens when a person does not have enough, not what happens when somebody who has enough takes more.
how much magnesium is in neuralisse
Eighty milligrams of elemental magnesium per capsule, printed on the panel at 19% of the Daily Value. That percentage is correct: the Daily Value is 420 mg and 80 ÷ 420 is 19.05%. It is about 23% of the 350 mg Tolerable Upper Intake Level the NIH Office of Dietary Supplements sets for supplemental magnesium, which is a sensible place for a magnesium capsule to sit.
neuralisse side effects
None is published by the manufacturer beyond the label’s caution block, which tells a reader not to exceed the dose, keeps the product away from under-eighteens and from pregnant or nursing mothers, and says to consult a physician if you take a medication or have a medical condition. From the federal fact sheets: high supplemental magnesium often causes diarrhoea, oral turmeric can cause digestive upset, and CoQ10 may interact with warfarin and insulin. The full account is here.
is neuralisse a scam
This desk publishes findings, not verdicts of that kind. The label is the best in this series — a real panel, correct arithmetic, a full caution block and a distributor with a city, state, ZIP, telephone and email. Against that: five of six ingredients are present in trace, the marketing bottle carries a disease word the real one does not, and all ten supplied reviews are the same ten supplied for an unrelated brand. Both review sets are printed side by side.
what does 95% curcuminoids mean
That the turmeric extract has been made to a standardised concentration of its measured constituents: 95% of the extract by weight is curcuminoids. It is the single most informative thing any label in this series has printed about an ingredient, and it is a genuine credit to this one. It does not make the amount larger: the turmeric is fifth of six inside a 7.5 mg remainder, so the ceiling is about 1.9 mg — a ceiling, not an amount.
how do i check a supplement label myself
Photograph the Supplement Facts panel square-on. Read the serving size, then the servings per container. Check any percentage against the published Daily Value. Note the blend total and count the names under it. Look above the blend for a declared nutrient sourced from a compound inside it. Then read the Other Ingredients line and the caution block. The seven steps are set out in full here.
References
Nine sources, all opened and read. Every quotation on this page is copied from the page linked here.
- U.S. Food and Drug Administration (2026). Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling.
- U.S. Food and Drug Administration (2026). Structure/Function Claims.
- NIH Office of Dietary Supplements (2026). Magnesium: Fact Sheet for Health Professionals.
- NIH Office of Dietary Supplements (2026). Magnesium: Fact Sheet for Health Professionals — nerve function.
- NIH Office of Dietary Supplements (2023). Carnitine: Fact Sheet for Health Professionals.
- National Center for Complementary and Integrative Health (2025). Turmeric: Usefulness and Safety.
- National Center for Complementary and Integrative Health (2019). Coenzyme Q10.
- Operation Supplement Safety, U.S. Department of Defense (2026). Proprietary blends: What does this mean?.
- U.S. Food and Drug Administration (2026). Questions and Answers on Dietary Supplements.
Read the blend row before you decide
Thirty capsules, one a day. The panel declares 80 mg of magnesium at 19% of the Daily Value, and a 575 mg blend of six ingredients. The magnesium declaration fixes the weight of the first ingredient at about 567.5 mg, which leaves roughly 7.5 mg for the other five together. No price appears anywhere but the checkout.
- Guarantee as printed at checkout
- 80 mg magnesium, 19% of the Daily Value
- Returns to 4 Times Square, Floor 22, New York, NY 10036, USA
No price appears in any document supplied to this desk, as of October 11, 2026, so none is printed here. The checkout screen is the only place a price exists. Questions first? Every published contact route is here.
Keep reading
Authorship and review
Who wrote and checked this page
What this page was checked against
- The label artwork, read at 2× and transcribed character for character. Where the label and the marketing disagree, the label is printed.
- The seller pack, quoted rather than paraphrased, and identified as marketing wherever it is used.
- The published sources listed in the references on this page. Every one was opened and read; none is cited from memory.
- The arithmetic, shown in full. Every per-ingredient figure other than the magnesium is a ceiling derived from one printed number, never a measured amount.
- Nothing else. Any fact that was not supplied is recorded as not published rather than filled in.
Last updated October 11, 2026. A highlighted slot is a value no human has supplied yet. Who reviews these pages?